OA07823A - Expression of plasmodium falsoparum polypeptides from cloned CDNA. - Google Patents

Expression of plasmodium falsoparum polypeptides from cloned CDNA.

Info

Publication number
OA07823A
OA07823A OA58399A OA58399A OA07823A OA 07823 A OA07823 A OA 07823A OA 58399 A OA58399 A OA 58399A OA 58399 A OA58399 A OA 58399A OA 07823 A OA07823 A OA 07823A
Authority
OA
OAPI
Prior art keywords
falsoparum
plasmodium
polypeptides
expression
cloned cdna
Prior art date
Application number
OA58399A
Other languages
English (en)
Inventor
James Kemp David Ph D
Fredric Anders Robin Ph D
Ross Leon Coppel B Surg
Vallancey Brown Graham Ph D
Bryce Saint Robert Ph D
Original Assignee
Inst Medical W & E Hall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Medical W & E Hall filed Critical Inst Medical W & E Hall
Publication of OA07823A publication Critical patent/OA07823A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02BINTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00Other engines
    • F02B75/02Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
OA58399A 1983-01-28 1984-09-25 Expression of plasmodium falsoparum polypeptides from cloned CDNA. OA07823A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPF784383 1983-01-28
AUPF978883 1983-06-10

Publications (1)

Publication Number Publication Date
OA07823A true OA07823A (en) 1986-11-20

Family

ID=25642630

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58399A OA07823A (en) 1983-01-28 1984-09-25 Expression of plasmodium falsoparum polypeptides from cloned CDNA.

Country Status (15)

Country Link
EP (1) EP0134799B1 (xx)
JP (1) JPH06225786A (xx)
AU (1) AU569722B2 (xx)
DE (1) DE3486110D1 (xx)
DK (1) DK467484D0 (xx)
ES (1) ES8606494A1 (xx)
GB (1) GB2143830B (xx)
GR (1) GR81750B (xx)
IL (1) IL70776A (xx)
MY (1) MY102594A (xx)
NO (1) NO843872L (xx)
OA (1) OA07823A (xx)
PT (1) PT78032B (xx)
SG (1) SG41089G (xx)
WO (1) WO1984002917A1 (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
EP0135108A3 (en) * 1983-08-12 1988-07-13 Rockefeller University Nucleotide hybridization assay for protozoan parasites
DE3584300D1 (de) * 1984-02-21 1991-11-14 Nat Res Dev Herstellung von malaria-impfstoffen.
HU200794B (en) * 1984-02-22 1990-08-28 Wellcome Found Process for expressing malaria antigenes
IL76338A (en) * 1984-09-11 1994-08-26 Saramane Pty Ltd Plasmodium plasmodium immunogenic polypeptides, AND molecules encoding them, a method for preparing the polypeptides and preparations containing the polypeptide
US5126264A (en) * 1984-09-11 1992-06-30 The Walter & Eliza Hall Institute Of Medical Research The RESA and FIRA antigens of plasmodium falciparum
DE3686178T2 (de) * 1985-02-07 1993-03-11 Smithkline Beckman Corp Malaria-impfstoff.
CN86100979A (zh) * 1985-02-07 1986-12-17 史密丝克莱恩贝克曼公司 疟疾疫苗的制备方法
JPS62502933A (ja) * 1985-02-20 1987-11-26 メモリアル スロ−ン−ケツタリング キヤンサ− センタ− 分子量130,000ダルトンと155,000ダルトンを持つプラスモディウム・ファルシパルムのグリコホリン結合蛋白に対するcDNAのコ−ド付け
WO1986006075A1 (en) * 1985-04-11 1986-10-23 The Walter And Eliza Hall Institute Of Medical Res Highly repetitive antigens of plasmodium falciparum
IL79880A0 (en) * 1985-08-29 1986-11-30 Inst Medical W & E Hall Recombinant virus
US5116755A (en) * 1985-12-24 1992-05-26 Kemp David J Asexual blood stage antigens of plasmodium falciparum which encode a rhoptry protein
IL81890A0 (en) * 1986-03-14 1987-10-20 Saramane Pty Ltd Polypeptides providing protective immunity against malaria
EP0261248B1 (en) * 1986-03-20 1991-05-29 Sawai Pharmaceutical Co., Ltd. $g(a), $g(a)-TREHALOSE TRIMYCOLATE AND MEDICINAL COMPOSITION
FR2672290B1 (fr) * 1991-02-05 1995-04-21 Pasteur Institut Sequences peptidiques specifiques des stades hepatiques de p. falciparum porteuses d'epitopes capables de stimuler les lymphocytes t.
FR2610631B1 (fr) * 1987-02-09 1989-11-24 Pasteur Institut Molecules comportant au moins une sequence peptidique porteuse d'un ou plusieurs, epitope caracteristique d'une proteine produite par p. falciparum dans les hepatocytes, et leurs utilisations, notamment pour le diagnostic du paludisme ou dans des compositions de vaccins contre le paludisme
DE3741057A1 (de) * 1987-03-18 1988-09-29 Behringwerke Ag Klonierung von malaria-spezifischen dna-sequenzen:isolierung des gens fuer das 140 kd protein
ZA888983B (en) * 1987-12-01 1989-08-30 Saramane Pty Ltd Rhoptry antigen of plasmodium falciparum
WO1989007645A1 (en) * 1988-02-12 1989-08-24 Saramane Pty. Ltd.; Rhoptry membrane antigen of plasmodium falciparum
GB8819209D0 (en) * 1988-08-12 1988-09-14 Research Corp Ltd Polypeptide & dna encoding same
US5231168A (en) * 1988-09-16 1993-07-27 Statens Seruminstitut Malaria antigen
CA2011031C (en) * 1989-03-14 2000-07-18 Robert George Ridley Plasmodium merozoite rhoptries antigen and derivatives thereof
GB8905857D0 (en) * 1989-03-14 1989-04-26 Hoffmann La Roche Plasmodium merozoite rhoptries antigen
GB9002512D0 (en) * 1990-02-05 1990-04-04 3I Res Expl Ltd Polypeptides and dna encoding same
KR20020028385A (ko) * 2000-10-09 2002-04-17 박제철 마커를 이용한 말라리아 원충에 감염된 모기 검출방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5434837B2 (xx) * 1972-02-08 1979-10-29
DE3033776A1 (de) * 1980-09-09 1982-04-22 Behringwerke Ag, 3550 Marburg Verfahren zur vermehrung von protozoen
FI64813C (fi) * 1980-12-31 1984-01-10 Ilkka Antero Palva Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
JPS57156421A (en) * 1981-03-24 1982-09-27 Nippon Koutai Kenkyusho:Kk Malaria vaccine and its preparation
ZA822539B (en) * 1981-04-15 1983-11-30 Wellcome Found Protozoal antigen
IL65496A (en) * 1981-04-15 1985-10-31 Wellcome Found Protozoal antigen,its preparation and vaccine containing it
EP0071705B1 (en) * 1981-05-21 1989-11-23 The Wellcome Foundation Limited Protozoal antigen
GB2099300B (en) * 1981-05-21 1985-02-27 Wellcome Found Antigens from parasites of the genus plasmodium
AU582112B2 (en) * 1982-02-17 1989-03-16 Lawrence E. D'antonio Purification of parasite protective antigen factors
DE3221881A1 (de) * 1982-06-09 1983-12-15 Münchener Apparatebau Kimmel GmbH, 8012 Ottobrunn Verfahren zur herstellung eines impfstoffs gegen parasitaere krankheitserreger

Also Published As

Publication number Publication date
PT78032A (en) 1984-02-01
SG41089G (en) 1989-12-22
DK467484A (da) 1984-09-28
EP0134799B1 (en) 1993-03-24
WO1984002917A1 (en) 1984-08-02
ES529232A0 (es) 1986-04-16
GB8424104D0 (en) 1984-10-31
DK467484D0 (da) 1984-09-28
NO843872L (no) 1984-09-27
EP0134799A4 (en) 1985-07-30
GB2143830A (en) 1985-02-20
AU2384284A (en) 1984-08-09
AU569722B2 (en) 1988-02-18
GR81750B (xx) 1984-12-12
PT78032B (en) 1986-03-27
JPH06225786A (ja) 1994-08-16
EP0134799A1 (en) 1985-03-27
MY102594A (en) 1992-08-17
GB2143830B (en) 1987-02-25
DE3486110D1 (de) 1993-04-29
IL70776A0 (en) 1984-04-30
IL70776A (en) 1991-09-16
ES8606494A1 (es) 1986-04-16
DE3486110T2 (xx) 1993-09-09

Similar Documents

Publication Publication Date Title
OA07823A (en) Expression of plasmodium falsoparum polypeptides from cloned CDNA.
EP0198015A4 (en) PRODUCTION OF POLYPEPTIDES SIMILAR TO STREPTAVIDINE.
GB8425710D0 (en) Modification of polypeptides
IL70811A0 (en) Glucoamylase cdna
ZA844082B (en) Polypeptides having interferon activity
EP0169239A4 (en) HUMAN ERYTHROPOIETIN cDNA CLONES.
ZA8410080B (en) Cloning of cdna for il-3
DE3471910D1 (en) Wide based semi-submersible vessel
GB8418736D0 (en) Manufacture of ceramic components
HK118293A (en) Expression of plasmodium falciparum polypeptides from cloned cdna
ZA822662B (en) Analogos of extended n-terminal somatostatin
DE3477592D1 (en) Space truss of metal
ZA84605B (en) Expression of plasmodium falciparum polypeptides from cloned cdna
EP0447808A3 (en) Expression of plasmodium falciparum polypeptides from cloned cdna
GB8501903D0 (en) Heat-resistant alloy
GB8404020D0 (en) Manufacture of tetrafluoroethylene
GB2138321B (en) Ceramic coatings
ZA84685B (en) Glucoamylase cdna
GB2154582B (en) Preparation of 2-chloro-5-trichloromethylpyridine from lower chlorinated beta-picolines
GB8311571D0 (en) Production of polypeptides
GB8309936D0 (en) Production of polypeptides
IL74084A0 (en) Human erythropoietin cdna clones
GB8323759D0 (en) Polypeptide
IE831978L (en) Polypeptides
IE831904L (en) Polypeptides